Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Boucher

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Cancer Research|March 3, 2006
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vectorTrevor D McKee, Paola Grandi, Wilson Mok, et al.
Plos One|February 21, 2012
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)Chandrajit P Raut, Yves Boucher, Dan G Duda, et al.
Cancer Research|May 17, 2011
Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumorsJean Y Perentes, Nathaniel D Kirkpatrick, Satoshi Nagano, et al.
NPJ Precision Oncology|June 30, 2021
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patientsYves Boucher, Ashwin S Kumar, Jessica M Posada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implicationsAlphonse G Taghian, Rita Abi-Raad, Sherif I Assaad, et al.
Journal of Oral Rehabilitation|July 15, 2024
Association between obstructive sleep apnea and temporomandibular disorders: A meta-analysisCláudia Aparecida de Oliveira Machado, Camila Maria Bastos Machado de Resende, Juliana Stuginski-Barbosa, et al.
Mediators of Inflammation|February 3, 2022
Salivary Biomarkers (Opiorphin, Cortisol, Amylase, and IgA) Related to Age, Sex, and Stress Perception in a Prospective Cohort of Healthy SchoolchildrenAnna Krahel, Elzbieta Paszynska, Justyna Otulakowska-Skrzynska, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2019
Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapyVikash P Chauhan, Ivy X Chen, Rong Tong, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Cancer Research|March 3, 2006
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vectorTrevor D McKee, Paola Grandi, Wilson Mok, et al.
Plos One|February 21, 2012
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)Chandrajit P Raut, Yves Boucher, Dan G Duda, et al.
Cancer Research|May 17, 2011
Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumorsJean Y Perentes, Nathaniel D Kirkpatrick, Satoshi Nagano, et al.
NPJ Precision Oncology|June 30, 2021
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patientsYves Boucher, Ashwin S Kumar, Jessica M Posada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implicationsAlphonse G Taghian, Rita Abi-Raad, Sherif I Assaad, et al.
Journal of Oral Rehabilitation|July 15, 2024
Association between obstructive sleep apnea and temporomandibular disorders: A meta-analysisCláudia Aparecida de Oliveira Machado, Camila Maria Bastos Machado de Resende, Juliana Stuginski-Barbosa, et al.
Mediators of Inflammation|February 3, 2022
Salivary Biomarkers (Opiorphin, Cortisol, Amylase, and IgA) Related to Age, Sex, and Stress Perception in a Prospective Cohort of Healthy SchoolchildrenAnna Krahel, Elzbieta Paszynska, Justyna Otulakowska-Skrzynska, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2019
Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapyVikash P Chauhan, Ivy X Chen, Rong Tong, et al.
Pageof 11